Section to complete information about primary and secondary outcomes including. It includes the metric or method of measurement used and, the time point for every outcome.
Primary outcome(s):
Cholesterol (value in mg/dL). Measurement time: at baseline (time 0) and 2 weeks
Triglycerides (value in mg/dL). Measurement time: at baseline (time 0) and 2 weeks
HDL-c (value in mg/dL). Measurement time: at baseline (time 0) and 2 weeks
LDL-c (value in mg/dL). Measurement time: at baseline (time 0) and 2 weeks
VLDL-C (value in mg/dL). Measurement time: at baseline (time 0) and 2 weeks
Atherogenic index (Castelli index). Measurement time: at baseline (time 0) and 2 weeks
Key secondary outcomes:
Efficacy outcomes:
1. Measurements and anthropometric indexes. Measurement time: at baseline (time 0) and 2 weeks. It will measure by:
-Body Max Index-BMI (Weight/(Height*Height). The weight expressed in Kg and, the height expressed in meters)
-Waist circumference (Value expressed in cm). Measurement time: at baseline (time 0) and 2 weeks
- Hip circumference (Value expressed in cm)
- Waist-hip Index (Waist circumference/Hip circumference. All values are expressed in cm).
2. Glucose on an empty stomach (Value expressed in mg/dL). Measurement time: at baseline (time 0) and 2 weeks.
3. Biochemistry test (BUN, Urea, Creatinine, Uric acid, Total bilirubin, Direct bilirubin, Indirect bilirubin, TGO, TGP, LDH, Alkaline phosphatase, GGT, Total proteins, Albumin, Globulin, Albumin-globulin ratio, Calcium, Phosphorus, CPK, Sodium, Potassium, Chlorine (All are expressed as numerical values in the measurement units of the institution). Measurement time: at baseline (time 0) and 2 weeks